5'-nitro-indirubinoxime을 처리한 구강 편평세포암종 KB 세포에서 유전자 발현의 변화 = Gene Expression Profiling in the KB Oral Squamous Cell Carcinoma Cells Treated with 5'-Nitro-Indirubinoxim

목차 (Table of Contents)

• ABSTRACT
• Ⅰ. 서론
• Ⅱ. 재료 및 방법
• Ⅲ. 결과
• Ⅳ. 고찰
• Ⅴ. 참고문헌

참고문헌 (Reference)

1 Raybaud-Diogene H, "p53 overexpression in head and neck squamous cell carcinoma: review of the literature." 32 : 143-149, 1996

2 Zhang Z.N, "Treatment of chronic myelocytic leukemia (CML) by traditional Chinese medicine and Western medicine alternately." 5 : 246-248, 1985

3 Han J, "Traditional Chinese medicine and the search for new antineoplastic drugs." 24 : 1-17, 1988

4 DeHahn K.C, "The alpha4 laminin subunit regulates endothelial cell survival." 294 : 281-289, 2004

5 Qin G.W, "Recent advances on bioactive natural products from Chinese medicinal plants." 18 : 375-382, 1998

6 Gu Y, "Processing and activation of CMH-1 by granzyme B." 271 : 1996

7 Marko D, "Inhibition of cyclin-dependent kinase 1 (CDK1) by indirubin derivatives in human tumour cells." 84 : 283-289, 2001

8 Lee J.W, "Induction of apoptosis by a novel indirubin-5-nitro-3'-monoxime, a CDK inhibitor, in human lung cancer cells." 15 : 3948-3952, 2005

9 Xie Y, "Indirubin- 3'-oxime inhibits c-Jun NH2-terminal kinase: anti-apoptotic effect in cerebellar granule neurons." 367 : 355-359, 2004

10 Xie Y, "Indirubin- 3'-oxime inhibits c-Jun NH2-terminal kinase: anti-apoptotic effect in cerebellar granule neurons." 367 : 355-359, 2004

11 Hoessel R, "Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases." 1 : 60-67, 1999

12 Nam S, "Indirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cells." 102 : 5998-6003, 2005

13 Adachi J, "Indirubin and indigo are potet aryl hydrocarbon receptor ligands present in human urine." 276 : 2001

14 Knockaert M, "Independent actions on cyclin-dependent kinases and aryl hydrocarbon receptor mediate the antiproliferative effects of indirubins." 23 : 4400-4412, 2004

15 Jeffers M, "Identification of a novel human fibroblast growth factor and characterization of its role in oncogenesis." 61 : 3131-3138, 2001

16 Nicholson D.W, "ICE/CED3-like proteases as therapeutic targets for the control of inappropriate apoptosis." 14 : 297-301, 1996

17 Duan H, "ICE-LAP3, a novel mammalian homologue of the Caenorhabditis elegans cell death protein Ced-3 is activated during Fas- and tumor necrosis factor-induced apoptosis." 271 : 1621-1625, 1996

18 Parkin D.M, "Global cancer statistics." 49 : 33-64, 1999

19 Chamorro M.N, "FGF-20 and DKK1 are transcriptional targets of beta-catenin and FGF-20 is implicated in cancer and development." 24 : 73-84, 2005

20 Thyboll J, "Deletion of the laminin alpha4 chain leads to impaired microvessel maturation." 22 : 1194-1202, 2002

21 Cohen G.M, "Caspases: the executioners of apoptosis." 326 : 1-16, 1997

22 Landis S.H, "Cancer statistics 1999" 49 : 8-31, 1999

23 Thompson C.B, "Apoptosis in the pathogenesis and treatment of disease." 267 : 1456-1462, 1995

24 Damiens E, "Anti-mitotic properties of indirubin-3'-monoxime, a CDK/GSK-3 inhibitor: induction of endoreplication following prophase arrest." 20 : 3786-3797, 2001

25 Chandler J.M, "Activation of CPP32 and Mch3 alpha in wild-type p53-induced apoptosis." 322 : 19-23, 1997